Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- Check6 days agoChange DetectedRecruitment status updated to no longer look for participants, and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check13 days agoChange DetectedA new revision entry (v3.5.5) appears in the study's record history, indicating that the record has been updated.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, indicating a new page release.SummaryDifference0.1%

- Check56 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision version from v3.5.2 to v3.5.3, indicating a minor application/version update rather than a change to the trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded revision v3.5.0 to the Record History and removed revision v3.4.3 from the history.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.